Ryan Zimmerman
Stock Analyst at BTIG
(4.05)
# 526
Out of 4,944 analysts
181
Total ratings
50.33%
Success rate
11.5%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KIDS OrthoPediatrics | Maintains: Buy | $40 → $39 | $20.09 | +94.13% | 8 | Aug 6, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $566 → $571 | $482.35 | +18.38% | 18 | Jul 23, 2025 | |
| RXST RxSight | Downgrades: Neutral | n/a | $8.31 | - | 5 | Jul 9, 2025 | |
| GMED Globus Medical | Downgrades: Neutral | n/a | $62.79 | - | 15 | May 27, 2025 | |
| VCEL Vericel | Maintains: Buy | $56 → $66 | $37.93 | +74.00% | 8 | Nov 26, 2024 | |
| PEN Penumbra | Maintains: Buy | $232 → $270 | $257.38 | +4.90% | 19 | Nov 26, 2024 | |
| GKOS Glaukos | Maintains: Buy | $140 → $149 | $91.79 | +62.33% | 10 | Nov 26, 2024 | |
| SYK Stryker | Maintains: Buy | $383 → $394 | $378.95 | +3.97% | 15 | Oct 30, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $1.78 | +461.80% | 4 | Oct 18, 2024 | |
| ALC Alcon | Maintains: Buy | $104 → $106 | $86.48 | +22.57% | 11 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $14.12 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $134 → $126 | $103.22 | +22.07% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $75.33 | +32.75% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $74.38 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $28.21 | +87.88% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.65 | +361.96% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.90 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.76 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.12 | +89.13% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.92 | +22.08% | 6 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.83 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $14.11 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $12.95 | +116.22% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $155.97 | +28.23% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $308.68 | +13.39% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $130 | $129.40 | +0.46% | 3 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $40.38 | - | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $92.91 | +37.77% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $12.76 | +17.55% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $68.98 | +31.92% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $18.75 | +124.00% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $5.14 | +921.40% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $14.76 | - | 3 | Apr 2, 2020 |
OrthoPediatrics
Aug 6, 2025
Maintains: Buy
Price Target: $40 → $39
Current: $20.09
Upside: +94.13%
Intuitive Surgical
Jul 23, 2025
Maintains: Buy
Price Target: $566 → $571
Current: $482.35
Upside: +18.38%
RxSight
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $8.31
Upside: -
Globus Medical
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $62.79
Upside: -
Vericel
Nov 26, 2024
Maintains: Buy
Price Target: $56 → $66
Current: $37.93
Upside: +74.00%
Penumbra
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $257.38
Upside: +4.90%
Glaukos
Nov 26, 2024
Maintains: Buy
Price Target: $140 → $149
Current: $91.79
Upside: +62.33%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $378.95
Upside: +3.97%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $1.78
Upside: +461.80%
Alcon
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $86.48
Upside: +22.57%
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $14.12
Upside: -
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $103.22
Upside: +22.07%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $75.33
Upside: +32.75%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $74.38
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $28.21
Upside: +87.88%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.65
Upside: +361.96%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.90
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.76
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $2.12
Upside: +89.13%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $4.92
Upside: +22.08%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $7.83
Upside: -
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $14.11
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $12.95
Upside: +116.22%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $155.97
Upside: +28.23%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $308.68
Upside: +13.39%
Apr 17, 2023
Maintains: Buy
Price Target: $125 → $130
Current: $129.40
Upside: +0.46%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $40.38
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $92.91
Upside: +37.77%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $12.76
Upside: +17.55%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $68.98
Upside: +31.92%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $18.75
Upside: +124.00%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $5.14
Upside: +921.40%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $14.76
Upside: -